Advancing drug delivery: New framework links lipid nanoparticle structure to immune response
A new framework bridges a gap in understanding RNA therapeutics by linking the structure of lipid nanoparticles to immune response.
A new framework bridges a gap in understanding RNA therapeutics by linking the structure of lipid nanoparticles to immune response.
Swagtron and Segway top our testing list...
There are benefits—and risks...
And should we even be saying it anymore...
NEW YORK — In the wake of details about the molecular pathophysiology of Waldenström macroglobulinemia (WM), an expert gave an
NEW YORK — In a three-way debate on whether to prioritize chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies (BsAbs),
A new study provides real-world evidence to support the potential repurposing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs), used
MedPage Today) -- The CDC's Advisory Committee on Immunization Practices (ACIP) on Thursday unanimously endorsed revising the dosing and interval
MedPage Today) -- DENVER -- In women with type 2 diabetes, use of GLP-1 receptor agonists was associated with a
MedPage Today) -- Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2
No posts found.